You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Israeli biotech firm MeMed is embarking on a series of new clinical studies and platform development efforts as it aims to expand the reach of its ImmunoXpert test, a proteomic tool for guiding the use of antibiotics.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.
Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.